The future of technology and AI in clinical trials with Joe Dustin

In this episode of Clinical Data Talks, host Sylvain Berthelot welcomes industry veteran Joe Dustin to explore the evolving landscape of eClinical technology and the impact of AI in clinical trials. With decades of experience across eClinical vendors and the sponsor side, Joe shares his insights into the major transformations shaping the industry - from paper-based processes to electronic data capture, on-premise systems to cloud platforms, and now, the rise of AI-driven solutions.

Together, they discuss the current challenges of interoperability and fragmentation in clinical data, the potential of AI to enhance data management and trial design, and how standardization efforts like the USDM (Unified Study Definitions Model) are paving the way for faster and more efficient studies.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

Beyond the data: Human stories from clinical trials in Ukraine

From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, Anna paints a vivid picture of resilience and resourcefulness under pressure.

Why Mednet. Why Now.

CRScube and Mednet are a natural fit. We are both innovators in eClinical technology. We both operate on a SaaS model, serve the same customers, and believe in transforming clinical trials.

CRScube acquires Mednet to expand global eClinical capabilities

“Bringing CRScube and Mednet together is an important milestone in our journey to transform clinical trials" said Stanley Kim, CEO of CRScube.